The targeting of AKR1C1 synergizes with gefitinib via the STAT3 signaling pathway in <i>EGFR</i>-mutated NSCLC.

ABSTRACT:

SUBMITTER: Chang L 

PROVIDER: S-EPMC12272410 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature